Calgary, Canada

Daniel Abraham Muruve

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Abraham Muruve

Introduction

Daniel Abraham Muruve is a notable inventor based in Calgary, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the area of reducing inflammation and treating various medical conditions. With a total of 5 patents to his name, Muruve's work has the potential to impact many lives positively.

Latest Patents

Muruve's latest patents include innovative pharmaceutical compositions and methods aimed at reducing inflammation in subjects. One of his key inventions is the DPEP-1 binding composition, which provides methods for blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis, and preventing or reducing acute kidney injury. Another significant patent is the DPEP-1 binding agents, which also focuses on similar therapeutic applications, showcasing his dedication to advancing medical science.

Career Highlights

Throughout his career, Muruve has worked with various companies, including Arch Biopartners, Inc. and Arch Biophysics, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of pharmaceutical research and development.

Collaborations

Muruve has collaborated with notable professionals in his field, including Stephen Mark Robbins and Donna Lorraine Senger. These partnerships have likely enriched his research and expanded the scope of his inventions.

Conclusion

Daniel Abraham Muruve's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…